Suppressor of cytokine signaling 3 is down-regulated by BCR-ABL and results in loss of JAK2 V617F in a patient with concurrent BCR-ABL translocation and JAK2 V617F mutation - Ang, C.H.; Gan, G.G.; Nadarajan, V. (Ferrata Storti Foundation, 2010)